Endometrial Cancer Biomarker Test Panel near me in Kattupakkam

The Endometrial Cancer Biomarker Test Panel is a comprehensive diagnostic package designed to support accurate tumor classification, molecular profiling, and personalized treatment planning for endometrial cancers. This package includes detailed histopathology reporting and expert review of up to 8 tissue blocks, ensuring precise evaluation of tumor type, grade, and pathological features that are critical for establishing a reliable diagnosis. It further incorporates Mismatch Repair (MMR) protein analysis by immunohistochemistry (IHC) to detect MMR deficiency or microsatellite instability, which plays a vital role in prognosis, hereditary cancer risk assessment, and determining eligibility for immunotherapy. In addition, the package comprises POLE gene mutation testing (exons 9–14) to identify ultra‑mutated tumors, a distinct molecular subtype associated with unique prognostic outcomes and therapeutic implications. By combining morphological and molecular insights, the package delivers a clinically actionable profile aligned with current international standards. Getting tested with the Endometrial Cancer Biomarker Test Panel empowers clinicians to make informed, evidence‑based treatment decisions, ensuring patients receive the most effective and individualized care in the management of endometrial cancer.

Note: One representative block of the tumor is required. However, 1-4 representative blocks of tumors are acceptable.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.